HPLC purity
Target specification: ≥99% area purity by reverse-phase HPLC with UV detection; actual acceptance criteria and result are confirmed for the applicable product and lot.
Growth-hormone axis · worldwide
CJC-1295 wholesale & OEM supply.
Lyophilized CJC-1295 — supplied with or without DAC (Drug Affinity Complex) — for qualified B2B research buyers, and private-label brand owners. Frequently requested alongside ipamorelin for laboratory research.
Lot CJC-5HPLC ≥ 99%MS confirmed5 mg (with or w/o DAC)
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | CJC-1295 (with or without DAC) |
|---|---|
| Class | GHRH analog |
| Molecular weight | ≈ 3367.8 g/mol (no DAC) · ≈ 3647.0 g/mol (with DAC) |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | With DAC: 2 mg, 5 mg, 10 mg; without DAC: 2 mg, 5 mg, 10 mg; no-DAC + Ipamorelin: 10 mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Storage | 2–8 °C protected from light; long-term −20 °C |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
CJC-1295 is often quoted alongside ipamorelin for combined GHRH + GHRP coverage. Specify with or without DAC in the quote notes.
Documentation
Every CJC-1295 lot ships with a batch document pack for the production lot.
COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the CJC-1295 reference profile.
Lot traceability
Lot code printed on vial label and reflected in the document pack. Reorders cite the prior lot for continuity.
FAQ
Common CJC-1295 questions from B2B buyers.
What is CJC-1295 and how does it differ with vs without DAC?
CJC-1295 is a GHRH analog. The DAC (Drug Affinity Complex) variant binds to serum albumin, extending half-life vs the no-DAC variant. The required variant should be specified in the research RFQ.
Why is CJC-1295 often paired with ipamorelin?
The pair covers complementary GHRH (CJC-1295) and GHRP (ipamorelin) pathways. We supply both as separate lyophilized vials.
What is the MOQ?
Sample lots from 1 kit (10 vials); production lots from 200 vials with tier pricing.
Can I order both DAC and no-DAC in the same shipment?
Yes — list both variants in the Quote Cart notes, we will quote each as a separate SKU on the invoice.
How is batch-document availability confirmed?
Yes. For the applicable lot, Pepti confirms the available document set during RFQ review. Depending on the product and lot, the set can include COA + HPLC + MS document pack and lot traceability.
Related compounds
Buyers sourcing CJC-1295 often also source these.
COA library search
Search public COAs for this product.
The public COA library is being expanded by product and specification. Use the search link below to check current public records for this item.